Although our research links exogenous KIAA1199 with the proliferation and migration of CCA cells, the specific mechanisms by which KIAA1199 affects CCA cells remain unclear (e.g., whether the effects are autonomous or nonautonomous and whether a KIAA1199 receptor or binding partner is involved). Here, CEMIP is linked to cholangiocarcinoma.